Advertisement

Experientia

, Volume 48, Issue 3, pp 301–304 | Cite as

Correlation between car ownership and leukaemia: Is non-occupational exposure to benzene from petrol and motor vehicle exhaust a causative factor in leukaemia and lymphoma?

  • S. P. Wolff
Article

Abstract

Although there is widespread agreement that many cancers have environmental causes we are often unable to see associations between specific cancers and exposure to environmental chemicals. One might also speulate that the more widespread, common-place and ‘normal’ a chemical exposure is perceived to be then the less likely it will be that the exposure is recognised, let alone be considered to cause cancer. Widespread contamination of air by chemicals associated with internal combustion may be an example of one such ‘invisible’ carcinogenic exposure. Yet evidence is available which suggests that many leukaemia and lymphoma cases, as well as other cancers, may be caused by this mundane and ubiquitous environmental contamination. The hypothesis is developed that leukaemia ‘clustering’ as well as national leukaemia incidence may be related to non-occupational exposure to benzene formed by petrol combustion and resulting from petrol evaporation1. The possible association between exposure to fuel vapours, internal combustion products and cancer merits much closer examination than it receives at present.

Key words

Leukaemia benzene motor vehicle air pollution socioeconomic indicators 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Wolff, S. P., Child Leukaemia — Curies or Cars? Nature346 (1990) 517.PubMedGoogle Scholar
  2. 2.
    Cairns, J., The Cancer Problem. Sci. Am., Nov. (1975) 64.Google Scholar
  3. 3.
    McLean, A. E. M., Hazards from chemicals: scientific questions and conflicts of interest. Proc. R. Soc. Lond. B.205 (1979) 179–197.PubMedGoogle Scholar
  4. 4.
    Black, D., Investigation of the possible increased incidence of cancer in West Cumbria. HMSO Publications, London 1984.Google Scholar
  5. 5.
    Kinlen, L. J., Clarke, K., and Hudson, C., Evidence from population mixing in British New Towns 1946–85 of an infective basis for childhood leukaemia. Lancet336 (1990) 577.PubMedGoogle Scholar
  6. 6.
    Peto, J., Radon and the risks of cancer. Nature345 (1990) 389.PubMedGoogle Scholar
  7. 7.
    Cook-Mozaffari, P. J., Darby, S. C., Doll, R., Forman, D., Hermon, C., Pike, M. C., and Vincent, T., Br. J. Cancer.59 (1989) 476.PubMedGoogle Scholar
  8. 8.
    Alexander, F. E., Rickets, T. J., McKinney, P. A., and Cartwright, R. A., Lancet336 (1990) 1461.PubMedGoogle Scholar
  9. 9.
    Sanders, B. M., White, G. C., and Draper, G. J., J. Epidemiol. Comm. Health35 (1981) 245.Google Scholar
  10. 10.
    McWhirter, W. R., Br. J. Cancer46 (1982) 640.PubMedGoogle Scholar
  11. 11.
    Fasal, E., Jackson, E. W., and Klauber, M. R., Brith characteristics and leukaemia in childhood. J. natl Cancer Inst.47 (1971) 509.Google Scholar
  12. 12.
    Carey, P. M., US Environmental Protection Agency Technical Report EPA-AA-TSS-PA-86-5, 1987.Google Scholar
  13. 13.
    International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 46. Diesels and Gasoline Engine Exhausts and Some Nitroarenes. IARC, Lyon, France 1989.Google Scholar
  14. 14.
    International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans Volume 29. Some Industrial Chemicals and Dyestuffs, pp 95–148. IARC, Lyon, France 1982.Google Scholar
  15. 15.
    World Health Organization: Air quality guidelines for Europe. WHO regional publications. European Series No. 23. 1987.Google Scholar
  16. 16.
    Thorburn, S., and Colenutt, B. A., Int. J. envir. Studies13 (1979) 265.Google Scholar
  17. 17.
    Gilks, J. M. L., Boelsma-v. Houte, E., Eyres, A. R., Rousseaux, G., Roythorne, C., Stanton, D. W., Thomas, F. C., and Simpson, B. J., Health risk of exposure to non-occupational sources of benzene, in: CONCAWE (the oil companies' European organisation for environmental and health protection) report No. 8/89. The Hague, Netherlands 1989.Google Scholar
  18. 18.
    Brief, R. S., Lynch, J., Bernath, T., and Scala, R. A., Am. ind. Hyg. Ass. J.41 (1980) 616–623.Google Scholar
  19. 19.
    Cartwright, R. A., Alexander, F. E., McKinney, P. a., and Rickets, T. J., Leukaemia and Lymphoma: an atlas of distribution within areas of England and Wales 1984–1988. London, Leukaemia Research Fund, 1990.Google Scholar
  20. 20.
    Office of Population Censuses and Surveys. Census 1981, Key Statistics for Local Authorities, HMSO, 1984.Google Scholar
  21. 21.
    Department of Transport, Transport Statistics Great Britain 1971 1981. HMSO, 1982.Google Scholar
  22. 22.
    Wolff, S. P., Leukaemia and Radon. Nature,352 (1991) 288.Google Scholar
  23. 23.
    Robinson, A. A., Med. Hypoth.9 (1982) 345.Google Scholar
  24. 24.
    Court-Brown, W. M., and Doll, R., Br. med. J. April (1961) 981.Google Scholar
  25. 25.
    Davis, D. L., Hoel, D., Fox, J., and Lopez, A., Lancet336 (1990) 474.PubMedGoogle Scholar
  26. 26.
    Goldstein, B. D., Occup. Med.: State Art Rev.3 (1988) 541.Google Scholar
  27. 27.
    Brandt, L., Nilsson, P. G., and Mitelman, F., Br. Med. J.1 (1978) 553.PubMedGoogle Scholar
  28. 28.
    Occupational Exposure to Benzene: Final Rule (29 CFR Part 1910), Federal Register 52:176 (11th Sept 1987) pp 34459–34578.Google Scholar
  29. 29.
    Goldstein, B. d., Risk assessment and risk management of benzene by the environmental protection agency. Banbury Report19 (1985) 293–304.Google Scholar
  30. 30.
    World Health Organisation: Air quality guidelines for Europe. WHO Regional Publications, European Series No. 23, 1987.Google Scholar
  31. 31.
    Aksoy, M., Erdem, S., and Dincol, G., Acta haemat.55 (1976) 65.PubMedGoogle Scholar
  32. 32.
    Enterline, P. e., Lancet2 (1979) 1021.Google Scholar
  33. 33.
    Vianna, N. J., and Polan, A., Lancet1 (1979) 1394.PubMedGoogle Scholar
  34. 34.
    Rinsky, R. A., Smith, A. B., Hornung, R., Filloon, T. G., Young, R. J., Okun, A. H., and Landrigan, P. J., N. Engl. J. Med.316 (1987) 1044.PubMedGoogle Scholar
  35. 35.
    Infante, P. F., and White, M. C., Am. J. ind. Med.7 (1985) 403.PubMedGoogle Scholar
  36. 36.
    Young, N., Am. J. ind. Med.15 (1989) 495.PubMedGoogle Scholar
  37. 37.
    Savitz, D. A., and Feingold, L., Scand. J. Work envir. Health15 (1989) 360.Google Scholar
  38. 38.
    Blumer, W., Jaumann, R., and Reich, Th., Schweiz. med. Rundschau (PRAXIS)61 (1972) 514.Google Scholar
  39. 39.
    Ippen, M., Fehr, R., and Krasemann, E. O., Versicherungsmedizin2 (1989) 39.Google Scholar
  40. 40.
    Blumer, W., Blumer, M., and Reich, Th., Fortschr. Med.95 (1977) 1497 and 1551.PubMedGoogle Scholar
  41. 41.
    Blumer, M., Blumer, W., and Reicht, Th., Env. Sci. Tech.11 (1977) 1082.Google Scholar
  42. 42.
    Graham, D., Green, L. C., and Roberts, M. J., In Search of Safety: Chemicals and Cancer Risk. Harvard University Press, 1988.Google Scholar
  43. 43.
    Aldhous, P., Nature347 (1990) 508.PubMedGoogle Scholar
  44. 44.
    Lutz, W. K., Poetzsch, J., Schlatter, J., and Schlatter, C., Trends pharmac. Sci.12 (1991) 214.Google Scholar

Copyright information

© Birkhäuser Verlag 1992

Authors and Affiliations

  • S. P. Wolff
    • 1
  1. 1.Toxicology Laboratory, Department of Clinical PharmacologyUniversity College and Middlesex School of Medicine, 5LondonEngland

Personalised recommendations